As shown in Figure 2A, deconvolution of the first cohort of n = ~1000 public microarrays showed higher rates of CD4+ T lymphocytes in cHL than in DLBCL, regardless of subtypes (p < 0.0001). The gene discussed is CD4; the disease is diffuse large B-cell lymphoma.